Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Intracervical and Intravaginal Application of Prostaglandin E2 for Induction of Labour in Term Pregnancies With Unfavourable Cervix

NCT04280874 is registered in ClinicalTrials.gov with Clinical Hospital Merkur as lead sponsor.

NCT NCT04280874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04280874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Intracervical and Intravaginal Application of Prostaglandin E2 for Induction of Labour in Term Pregnancies With Unfavourable Cervix
Lead sponsor
Clinical Hospital Merkur
Phase
Phase 4
Overall status
Completed
Start date
December 10, 2018
Completion date
July 1, 2020
Enrollment
212 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

induction of labor affected fetus / newborn, prostaglandins causing adverse effects in therapeutic use